Prenatal organochlorine pollutant exposure and risk of schizophrenia in a national birth cohort.


Journal

Neurotoxicology
ISSN: 1872-9711
Titre abrégé: Neurotoxicology
Pays: Netherlands
ID NLM: 7905589

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 11 01 2023
revised: 04 03 2023
accepted: 15 05 2023
pmc-release: 01 07 2024
medline: 17 7 2023
pubmed: 19 5 2023
entrez: 18 5 2023
Statut: ppublish

Résumé

Non-genetic prenatal exposures have been associated with schizophrenia risk. However, the role of prenatal exposure to environmental neurotoxicants in offspring schizophrenia risk has been studied in only limited instances. Polychlorinated biphenyls (PCBs) and the pesticide metabolite p,p'-dichlorodiphenyl dichloroethylene (DDE) have been linked to neurodevelopmental outcomes, including impairments implicated in schizophrenia. To determine whether prenatal maternal levels of organochlorine pollutants including PCBs or DDE are associated with schizophrenia in the offspring, an investigation was conducted in the Finnish Prenatal Study of Schizophrenia (FIPS-S), a case-control study nested in a national birth cohort. Cases were born in 1987-1991 and had at least two diagnoses of schizophrenia (ICD-10 F20; ICD-9 295) or schizoaffective disorder (ICD-10 F25; ICD-9 295.7) recorded in the national Care Register for Health Care. Each case was individually matched to a control on sex, date of birth, and residence in Finland on the date of case diagnosis. In 500 case-control pairs, PCB congeners 74, 99, 118, 138, 153, 156, 170, 180, 183, 187, and some widespread organochlorine pesticides or their metabolites including DDE were measured in archived prenatal maternal sera using gas chromatography - high triple quadrupole mass spectrometry. Maternal total PCBs were quantified as the sum of concentrations of the measured congeners. Associations with schizophrenia were examined using conditional logistic regression. Maternal PCB or DDE levels greater than the 75th percentiles of the control distributions showed no evidence of association with offspring schizophrenia (PCBs: adjusted odds ratio (aOR) = 1.13, 95 % CI = 0.85-1.50), p = 0.41; DDE: aOR = 1.08, 95 % CI = 0.80-1.45; p = 0.63). Maternal levels of either pollutant dichotomized at the 90th percentile or considered as a continuous variable also did not show evidence for association with offspring schizophrenia. This study found a lack of evidence that prenatal maternal levels of the organochlorine pollutants DDE and PCBs are associated with offspring risk of schizophrenia.

Identifiants

pubmed: 37201646
pii: S0161-813X(23)00076-1
doi: 10.1016/j.neuro.2023.05.010
pmc: PMC10525014
mid: NIHMS1904228
pii:
doi:

Substances chimiques

2,4,4',5-tetrachlorobiphenyl W0250484DW
Polychlorinated Biphenyls DFC2HB4I0K
Environmental Pollutants 0
Dichlorodiphenyl Dichloroethylene 4M7FS82U08
Pesticides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-52

Subventions

Organisme : NIEHS NIH HHS
ID : R01 ES028125
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Alan S. Brown reports financial support was provided by National Institute of Environmental Health Sciences.

Références

Environ Res. 2022 Sep;212(Pt A):113145
pubmed: 35318010
Environ Health Perspect. 2008 Nov;116(11):1586-90
pubmed: 19057716
Pediatrics. 2006 Jul;118(1):233-41
pubmed: 16818570
Soc Psychiatry Psychiatr Epidemiol. 2005 Oct;40(10):808-16
pubmed: 16177843
J Chromatogr A. 2013 Sep 27;1309:48-55
pubmed: 23972455
Environ Health Perspect. 2017 Mar;125(3):474-480
pubmed: 27548254
Am J Epidemiol. 2010 Mar 1;171(5):593-601
pubmed: 20106937
Annu Rev Clin Psychol. 2014;10:425-48
pubmed: 24313570
Biol Psychiatry. 2016 Jun 15;79(12):962-70
pubmed: 26194598
Chemosphere. 2009 Aug;76(6):747-54
pubmed: 19539348
N Engl J Med. 1996 Sep 12;335(11):783-9
pubmed: 8703183
Chemosphere. 2012 Aug;88(7):828-31
pubmed: 22546635
Lancet. 2016 Jul 2;388(10039):86-97
pubmed: 26777917
Br J Psychiatry. 2008 Nov;193(5):364-72
pubmed: 18978313
Lancet Psychiatry. 2020 May;7(5):399-410
pubmed: 32220288
Reprod Sci. 2008 Sep;15(7):631-50
pubmed: 18836129
J Pediatr. 1999 Jan;134(1):33-41
pubmed: 9880446
Environ Health. 2012 Jan 20;11:2
pubmed: 22264316
Neurotoxicol Teratol. 2013 Jul-Aug;38:1-5
pubmed: 23591055
Epidemiol Rev. 2008;30:67-76
pubmed: 18480098
Am J Psychiatry. 2018 Nov 1;175(11):1094-1101
pubmed: 30111184
Environ Health Perspect. 2004 Apr;112(5):548-52
pubmed: 15064159
Schizophr Bull. 1994;20(3):441-51
pubmed: 7526446
Am J Psychiatry. 2014 Sep;171(9):960-8
pubmed: 24969261
Neurotoxicol Teratol. 2000 Jan-Feb;22(1):21-9
pubmed: 10642111
MMWR Surveill Summ. 2018 Nov 16;65(13):1-23
pubmed: 30439868
Am J Psychiatry. 2016 Aug 1;173(8):799-806
pubmed: 27216261
Schizophr Bull. 2018 Oct 17;44(6):1195-1203
pubmed: 29762765
Chemosphere. 2005 Aug;60(7):854-69
pubmed: 15992592
Environ Health Perspect. 2007 Mar;115(3):435-9
pubmed: 17431495
Front Psychiatry. 2020 Jun 11;11:548
pubmed: 32595540
Am J Psychiatry. 2008 May;165(5):579-87
pubmed: 18413704
Schizophr Res. 2007 Feb;90(1-3):251-4
pubmed: 17113267
Schizophr Res. 2022 Sep;247:7-15
pubmed: 34016508
J Environ Monit. 2011 Feb;13(2):241-51
pubmed: 21127808
Int J Hyg Environ Health. 2016 Jul;219(4-5):331-42
pubmed: 27216159
Environ Health Perspect. 2011 Jun;119(6):878-85
pubmed: 21233055
J Proteomics. 2012 Apr 18;75(8):2417-30
pubmed: 22387315

Auteurs

Keely Cheslack-Postava (K)

Department of Psychiatry, New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: kc2497@cumc.columbia.edu.

Panu Rantakokko (P)

Department of Health Security, Finnish Institute for Health and Welfare (THL), Kuopio, Finland.

Heljä-Marja Surcel (HM)

Faculty of Medicine, University of Oulu, Oulu, Finland; Biobank Borealis of Northern Finland, Oulu, Finland.

Susanna Hinkka-Yli-Salomäki (S)

Department of Child Psychiatry, Research Centre for Child Psychiatry, Institute of Clinical Medicine, Faculty of Medicine, University of Turku, Turku, Finland.

Joonas Laitinen (J)

Department of Child Psychiatry, Research Centre for Child Psychiatry, Institute of Clinical Medicine, Faculty of Medicine, University of Turku, Turku, Finland.

Subina Upadhyaya (S)

Department of Child Psychiatry, Research Centre for Child Psychiatry, Institute of Clinical Medicine, Faculty of Medicine, University of Turku, Turku, Finland.

Ian W McKeague (IW)

Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA.

Andre Sourander (A)

Department of Child Psychiatry, Research Centre for Child Psychiatry, Institute of Clinical Medicine, Faculty of Medicine, University of Turku, Turku, Finland; Department of Child Psychiatry, Turku University Hospital, Turku, Finland; INVEST Research Flagship, University of Turku, Turku, Finland.

Alan S Brown (AS)

Department of Psychiatry, New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, NY, USA; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH